Elite Pharmaceuticals, Inc. (ELTP)
0.2891
-0.01
(-2.00%)
USD |
OTCM |
Aug 24, 16:00
Elite Pharmaceuticals Debt to Equity Ratio : 0.0532 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0532 |
| March 31, 2026 | 0.0588 |
| December 31, 2025 | 0.0754 |
| September 30, 2025 | 0.1022 |
| June 30, 2025 | 0.14 |
| March 31, 2025 | 0.204 |
| December 31, 2024 | 0.3067 |
| September 30, 2024 | 0.2411 |
| June 30, 2024 | 0.2002 |
| March 31, 2024 | 0.2038 |
| December 31, 2023 | 0.1699 |
| September 30, 2023 | 0.1697 |
| June 30, 2023 | 0.2603 |
| March 31, 2023 | 0.1342 |
| December 31, 2022 | 0.5296 |
| September 30, 2022 | 0.5907 |
| June 30, 2022 | 0.573 |
| March 31, 2022 | 0.1103 |
| December 31, 2021 | 0.1282 |
| September 30, 2021 | 0.1528 |
| June 30, 2021 | 0.1848 |
| March 31, 2021 | 0.1473 |
| December 31, 2020 | 0.2807 |
| September 30, 2020 | 0.3248 |
| June 30, 2020 | 0.4268 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.378 |
| December 31, 2019 | 0.4334 |
| September 30, 2019 | 0.3736 |
| June 30, 2019 | 0.3569 |
| March 31, 2019 | 0.3493 |
| December 31, 2018 | 0.2922 |
| September 30, 2018 | 0.2424 |
| June 30, 2018 | 0.2353 |
| March 31, 2018 | 0.2157 |
| December 31, 2017 | 0.1931 |
| September 30, 2017 | 0.187 |
| June 30, 2017 | 0.2195 |
| March 31, 2017 | 0.1032 |
| December 31, 2016 | 0.0973 |
| September 30, 2016 | 0.1064 |
| June 30, 2016 | 0.1686 |
| March 31, 2016 | 0.28 |
| December 31, 2015 | -1.526 |
| September 30, 2015 | 0.2184 |
| June 30, 2015 | 0.3507 |
| March 31, 2015 | -0.0899 |
| December 31, 2014 | -1.162 |
| September 30, 2014 | -0.8862 |
| June 30, 2014 | -0.0485 |
| March 31, 2014 | -0.7995 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Nektar Therapeutics | 0.1505 |
| Daré Bioscience, Inc. | -12.08 |
| Eton Pharmaceuticals, Inc. | 0.6273 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 139.67M |
| Total Liabilities (Quarterly) | 34.84M |
| Shareholders Equity (Quarterly) | 104.83M |
| Current Ratio | 3.761 |
| Net Debt Paydown Yield | 0.27% |